Source: International Congress 2014 – Rationale behind respiratory drug development
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Marchand, C. Maria, M. Pinel, T. Nicolini, L. Vecellio (Tours, Saint Etienne, France). The performance of a new vibrating mesh prototype nebulizer for inhaled biodrugs. Eur Respir J 2014; 44: Suppl. 58, 936

Member's Comments

No comment yet.

Related content which might interest you: Are ultrafine particle inhalers, better for patients with small airway involvement? Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Are extra-fine particles from dry powder inhalers likely to improve lung deposition? Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Inhaled medication delivery to infants via valved holding chamber with facemask: Not all VHCs perform the same Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014 Effectively targeting small airways using controlled inhalation for peripheral corticosteroid deposition Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 First in class, respiratory drug gas & drug vapor delivered in a revolutionary and new portable device Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 Predictors of good inhaler technique in asthma and COPD Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 The effect of inhalation duration on lung deposition with a pressurized metered-dose inhaler (pMDI) Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Lung deposition analysis of two formulations of fluticasone/salmeterol HFA pMDI in stable asthma patients Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Atomization inhalation on the NO content in the airway of patients with bronchial asthma Source: International Congress 2016 – The wide spectrum of respiratory nursing research and practice: across all ages and diseases Year: 2016 Impact of inhaler technique on patient outcomes in asthma patients using diskus in primary care Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 Determinants of exhaled particles of a standardized breathing maneuver Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Importance of inhalation device in asthma and COPD: A consensus using Delphi Source: Annual Congress 2013 –Is it really asthma? Year: 2013 Do correct steps using pMDI technique with spacer predict no exacerbations of Asthma or COPD? Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Extent of inhaled drug deposition at variable inhaler inclination angles and airway geometries: An in-vivo study from a novel computational fluid dynamics model Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Acceptability and effectiveness of a new device in the management of airways clearance Source: Annual Congress 2013 –The latest insights in chronic care Year: 2013 Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Efficacy and safety of indacaterol acetate on ICS background therapy in asthma Source: International Congress 2014 – Asthma and COPD management Year: 2014 Efficacy of carbamazepine in treatment of bronchial asthma Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013 Satisfaction survey on the use of breath actuated Inhaler Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014